Literature DB >> 24924806

CXCR-7 receptor promotes SDF-1α-induced migration of bone marrow mesenchymal stem cells in the transient cerebral ischemia/reperfusion rat hippocampus.

Yulan Wang1, Wei Fu2, Shichun Zhang3, Xiaomei He3, Zhi'an Liu3, Diansuai Gao3, Tiejun Xu3.   

Abstract

The stromal cell-derived factor 1/C-X-C chemokine receptor type 4 (SDF-1/CXCR-4) axis plays an important role during stem cell recruitment. SDF-1 can also bind the more recently described CXCR-7 receptor, but effects of SDF-1/CXCR-7 signaling on stem cell migrating to ischemic brain injury area are little known. In the present study, we investigated the effect of CXCR-7 on bone marrow mesenchymal stem cell (BMSC) migration toward SDF-1α in the cerebral ischemia/reperfusion (I/R) rat hippocampus. We cultured BMSCs from rats and characterized them using flow cytometry, immunocytochemistry, western blotting, and immunofluorescence to detect SDF-1α, CXCR-4, and CXCR-7 expression in third passage BMSCs (P3-BMSCs). We also prepared the model of transient cerebral I/R by four-vessel occlusion (4-VO), and BMSCs were transplanted into I/R rat brain via lateral ventricle (LV) injection (20μl, 1×10(6)/ml). After that, we examined the effect of BMSCs migration in the cerebral I/R rat hippocampus through Transwell chamber assay. Our results show that SDF-1α, CXCR-4, and CXCR-7 were expressed in P3-BMSCs. Moreover, SDF-1α expression was increased in I/R hippocampus. At 48h after transplant, green fluorescent BrdU-BMSCs were observed in transplant groups, but no green fluorescent BrdU-BMSCs were seen in medium group. Among BMSCs transplant groups, the number of BrdU-BMSCs positive cell was the highest in BMSC group. Treatment with AMD3100 and/or CXCR-7 neutralizing antibody decreased the number of BMSC migration. Collectively, these findings indicate that CXCR-4 and -7 receptors were co-expressed in BMSCs and synergistically promoted BMSC migration. The effect of CXCR-7 was stronger than that of CXCR-4. Moreover, BMSCs that migrated to hippocampus promoted the autocrine and paracrine signaling of SDF-1α.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bone marrow mesenchymal stem cell; C-X-C chemokine receptor 7; Hippocampus; Ischemia/reperfusion; Migration; Stromal cell-derived factor-1α

Mesh:

Substances:

Year:  2014        PMID: 24924806     DOI: 10.1016/j.brainres.2014.05.035

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

1.  Lithium enhanced cell proliferation and differentiation of mesenchymal stem cells to neural cells in rat spinal cord.

Authors:  Bao-Tie Dong; Guan-Jun Tu; Ya-Xin Han; Yi Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?

Authors:  Ann De Becker; Ivan Van Riet
Journal:  World J Stem Cells       Date:  2016-03-26       Impact factor: 5.326

3.  G-CSF and hypoxic conditioning improve the proliferation, neural differentiation and migration of canine bone marrow mesenchymal stem cells.

Authors:  Jing Yu; Xing-Long Liu; Qi-Guang Cheng; Shan-Shan Lu; Xiao-Quan Xu; Qing-Quan Zu; Sheng Liu
Journal:  Exp Ther Med       Date:  2016-07-20       Impact factor: 2.447

4.  Low-dose nicotine reduces the homing ability of murine BMSCs during fracture healing.

Authors:  Jing Zhang; Qilong Wan; Xin Yu; Gu Cheng; Yifeng Ni; Zubing Li
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

5.  Localized CCR2 Activation in the Bone Marrow Niche Mobilizes Monocytes by Desensitizing CXCR4.

Authors:  Hosung Jung; Divakar S Mithal; Jeong Eun Park; Richard J Miller
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

Review 6.  Genetic Engineering of Mesenchymal Stem Cells to Induce Their Migration and Survival.

Authors:  Adam Nowakowski; Piotr Walczak; Barbara Lukomska; Miroslaw Janowski
Journal:  Stem Cells Int       Date:  2016-05-03       Impact factor: 5.443

7.  Possible Mechanism of Therapeutic Effect of 3-Methyl-1-phenyl-2-pyrazolin-5-one and Bone Marrow Stromal Cells Combination Treatment in Rat Ischemic Stroke Model.

Authors:  Li-Hua Shen; Jin Chen; Hua-Chao Shen; Min Ye; Xiao-Fei Liu; Wen-Sen Ding; Ya-Feng Sheng; Xin-Sheng Ding
Journal:  Chin Med J (Engl)       Date:  2016-06-20       Impact factor: 2.628

Review 8.  Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies.

Authors:  Guihong Li; Fengbo Yu; Ting Lei; Haijun Gao; Peiwen Li; Yuxue Sun; Haiyan Huang; Qingchun Mu
Journal:  Neural Regen Res       Date:  2016-06       Impact factor: 5.135

9.  Prophylactic Chronic Zinc Administration Increases Neuroinflammation in a Hypoxia-Ischemia Model.

Authors:  Constantino Tomas-Sanchez; Victor Manuel Blanco-Alvarez; Juan Antonio Gonzalez-Barrios; Daniel Martinez-Fong; Guadalupe Garcia-Robles; Guadalupe Soto-Rodriguez; Eduardo Brambila; Maricela Torres-Soto; Alejandro Gonzalez-Vazquez; Ana Karina Aguilar-Peralta; José-Luis Garate-Morales; Luis-Angel Aguilar-Carrasco; Daniel I Limón; Jorge Cebada; Bertha Alicia Leon-Chavez
Journal:  J Immunol Res       Date:  2016-08-18       Impact factor: 4.818

10.  Characterization of bone marrow-derived mesenchymal stem cells from dimethyloxallyl glycine-preconditioned mice: Evaluation of the feasibility of dimethyloxallyl glycine as a mobilization agent.

Authors:  Tingting Ge; Qin Yu; Wei Liu; Li Cong; Lizhen Liu; Yan Wang; Liping Zhou; Deju Lin
Journal:  Mol Med Rep       Date:  2016-02-29       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.